StockWatch
·
Medical Specialities
Quarterly ResultJul 29, 2026, 02:21 PM

Humana Q2 Revenue +26.2% to $40.87B; Net Income +27.3% to $694M

AI Summary

Humana Inc. reported strong financial results for the second quarter and first half of 2026, driven by significant revenue and net income growth. The company's total revenues for Q2 2026 increased by 26.2% to $40.87 billion, with net income attributable to Humana rising 27.3% to $694 million. This period also saw the acquisition of MaxHealth for $908 million and substantial growth in operating cash flow, alongside ongoing value creation initiatives.

Key Highlights

  • Acquired MaxHealth for $908 million in cash, adding $800 million in goodwill.
  • Q2 2026 total revenues increased 26.2% to $40.87 billion from $32.39 billion.
  • Q2 2026 net income attributable to Humana rose 27.3% to $694 million from $545 million.
  • Q2 2026 basic EPS grew 27.9% to $5.78 from $4.52.
  • Net cash provided by operating activities for H1 2026 surged 101.0% to $3.22 billion.
  • Recorded $56 million in charges for value creation initiatives in Q2 2026.
  • Total assets increased to $57.20 billion at June 30, 2026, from $48.91 billion at Dec 31, 2025.
  • Total stockholders' equity increased to $19.21 billion at June 30, 2026, from $17.66 billion at Dec 31, 2025.